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The global prevalence of colorectal cancer (CRC) is currently the highest in 
high-income countries. However, a rapid increase in prevalence is starting to 
emerge in many low-income and middle-income countries. This phenomenon is 
thought to be related to the adoption of a Western lifestyle, characterized by a lack 
of physical activity, the consumption of refined cereals, as well as highly processed 
foods. Other characteristics include a reduction in fruit and vegetable intake with 
a concomitant increase in the consumption of foods that are energy dense, but 
lacking in micronutrients. Coupled to the above dietary and lifestyle changes is 
the advent of an increased prevalence of body fatness and central obesity, as well 
as a dietary intake that lends itself to increasing the risk of developing CRC. As 
there are observed inconsistencies when appraising the effectivity of dietary and 
lifestyle-cancer relationships, this chapter will provide an overview of the current 
body of evidence regarding the role of diet and proxies for lifestyle in terms of their 
preventative or causative roles in the development of CRC. In addition, the strength 
of scientific evidence will be alluded to, as well as the modulating pathways respon-
sible for CRC causation or protection.
Keywords: alcohol, body fatness, colorectal cancer, dairy products, diet, dietary fiber, 
fruits, vegetables, physical activity, processed meat, red meat, supplements
1. Introduction
Globally, colorectal cancer (CRC) is the third most commonly diagnosed 
malignancy and the fourth leading cause of cancer-related mortality, accounting 
for about 1.4 million new cases and almost 700,000 deaths in 2012 [1]. Its disease 
burden is expected to increase by 60%, resulting in over 2.2 million new cases 
and 1.1 million cancer deaths by 2030 [2]. The distribution of CRC burden varies 
widely across regions, as more than two-thirds of all cases and about 60% of all 
deaths occur in countries with a high or very high Human Development Index 
[1]. However, CRC is considered to be one of the strongest indicators of the global 
cancer transition, as countries undergoing rapid social and economic transition 
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are displaying rapid increases in the prevalence of cancers that are already more 
widespread in high-income countries [2]. Hence, CRC incidence and mortality rates 
are still rapidly increasing in many low-income and middle-income countries, while 
stabilizing or decreasing trends are being observed in highly developed countries 
where rates remain among the highest in the world [2]. As patterns and trends in 
CRC incidence and mortality are related to development levels, their incremental 
changes could be indicative of the adoption of a more Westernized lifestyle [2].
Targeted interventions tailored to available resources, including primary 
prevention, are necessary to decrease the global prevalence of CRC [2], as primary 
prevention dietary habits and other healthy lifestyle factors such as physical activity 
(PA) are viewed as the most effective and affordable strategy for curbing this global 
epidemic [3, 4]. In addition, genetic predisposition and environmental factors 
including diet and PA are considered to be the two main causes of CRC [3, 5].
Due to observed inconsistencies when appraising the effectivity of dietary 
and lifestyle-cancer relationships, this chapter will provide an overview of the 
current body of evidence regarding the role of diet, individual foods, alcoholic 
beverages, vitamins, body fatness, physical activity, and dietary supplements 
in terms of their classification as preventative or causative in the development 
of CRC. In addition, the strength of scientific evidence will be alluded to, as 
well as the modulating pathways responsible for reaping protective benefits 
or promoting carcinogenesis. Inconsistent findings across scientific literature 
related to dietary prevention of CRC include but are not limited to discrepan-
cies in study design, dietary interventions assessed, baseline eating patterns, 
and populations sampled [6].
2. Diet
2.1 Dietary fiber
Dietary fiber refers to carbohydrate polymers of plant origin that may or may 
not be associated to plant lignin [7]. There is convincing evidence that consuming 
wholegrains and foods containing dietary fiber decrease the risk of developing 
CRC [8]. A meta-analysis of prospective studies noted a 10% reduction in CRC risk 
for every 10 g of total dietary fiber consumed on a daily basis [9]. An analysis of 
specific sources of dietary fiber found that cereal fiber was associated with a dose-
dependent reduction in risk of 10% for every 10 g consumed; however, fruit fibers, 
vegetable fibers, and legume fibers were not associated with a significant reduction 
in risk. A meta-analysis of case-control studies and cohort studies on dietary fiber 
intake and the incidence of CRC adenoma reported similar findings [10].
The European Prospective Investigation into Cancer and Nutrition (EPIC) 
supports the protective effect of dietary fiber, as the consumption of cereal fiber 
was significantly and inversely associated with colorectal cancer, colon cancer, 
and rectal cancer [11]. A significant inverse association was also noted between 
colon cancer and combined fruit and vegetable fiber intake, although the study was 
limited by dietary intake assessment conducted at baseline [12].
The HELGA prospective study agrees with previous studies, as a 26% reduction 
in colon cancer risk in men was reported for every 10 g of dietary fiber consumed 
on a daily basis. However, the association was not significant in women, thereby 
suggesting that dietary fiber may be protective against CRC, but other factors such 
as phytochemicals, energy intake, body weight, and genetics may be equally influ-
ential, as is general dietary pattern [13]. This finding serves to demonstrate that 
consuming dietary fiber from a variety of sources (cereals, fruits, and vegetables) 
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protects against the development of CRC in a dose-dependent manner. Based on the 
convincing evidence available, it would be reasonable to recommend an increased 
intake of wholegrains to help reduce the risk of CRC [4].
2.1.1 Mechanism
Dietary fiber found in wholegrains may protect against the development of CRC 
by increasing fecal bulk through binding water and decreasing colonic transit time, 
thereby reducing the potential for fecal mutagens to interact with the colon mucosa, 
lowering the concentration of potential carcinogens, and exposing the colon mucosa 
to potential carcinogens for shorter period of time [4, 12, 14–17]. In addition, dietary 
fiber is fermented by intestinal microbiota into short-chain fatty acids (SCFAs) such 
as butyrate, which in experimental studies was shown to have antiproliferative and 
pro-apoptosis properties [4, 14–18]. SCFAs also lower fecal pH in the colon, thus 
providing a healthy intestinal environment [18], as well as inhibit chronic inflam-
mation and cancer cell migration/invasion in the colon. However, these activities are 
only effective within certain physiological concentration ranges of SCFAs [18].
Other mechanisms include a reduction in secondary bile acid production [14], 
as well as enhancing the health of colonocytes [12] by modifying the composition 
of gut microbiota that can enhance immunity [18]. High-fiber diets may also reduce 
insulin resistance, a risk factor for CRC [7, 8, 14–16], by decreasing insulin growth 
factor (IGF)-1 activity, decreasing systemic inflammation via the production of 
SCFAs, and enhancing levels of colonic microbiota, thereby strengthening the 
intestinal barrier [4, 15, 16]. The anticarcinogenic properties of wholegrains also 
include being a source of antioxidants such as vitamin E, selenium, copper, zinc, 
and phytochemicals, as well as decreasing body adiposity [4, 14]. Wholegrains are 
also sources of lignans, phytoestrogens, and phenolic compounds [14], with many of 
these bioactive compounds being largely found in the bran and germ of the grain. To 
illustrate the plausible anticarcinogenic properties of several phenolic acids, experi-
mental studies have showcased their ability to stimulate anti-oxidative activity [19].
2.2 Dairy products
Dairy products include milk (whole or skim milk), cheese (fresh, cottage, and 
hard cheese), and yogurt [17]. There is strong probable evidence that consuming 
dairy products, i.e., total dairy, milk, cheese, and dietary calcium, decreases the 
risk of CRC [8]. Dose-response meta-analyses of dairy products, milk, and dietary 
calcium were statistically significant with little or no heterogeneity. However, the 
evidence for cheese was not as strong as for other dairy products, with prospective 
studies finding no association between cheese intake and CRC risk, thus qualifying 
the level of evidence as not conclusive [7]. A pooled analysis reported significant 
inverse associations when comparing the highest with the lowest levels of milk intake 
and dietary calcium. Hence, there is evidence of plausible mechanisms in humans [8]. 
As there is probable evidence that milk consumption protects against CRC, it may be 
reasonable to encourage the consumption of milk for the prevention of CRC [4].
2.2.1 Mechanism
Dairy products contain a variety of bioactive compounds that could be related to 
simultaneous positive or negative effects on carcinogenesis. The overriding theory 
underpinning the possible protective effect of dairy products against cancer risk 
is related to their calcium and to a lesser extent, their vitamin D, lactoferrin, and 
fermentation products [4, 20, 21]. In addition, dairy products have the ability to 
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modulate inflammatory responses [22]. Lactic acid-producing bacteria may also 
protect against CRC [20], while the casein and lactose in milk may increase calcium 
bioavailability [4, 23]. Lastly, the anticarcinogenic effect of milk is also related to its 
conjugated linoleic acid and butyric acid content [4].
2.3 Red meat
There is strong probable evidence from epidemiologic studies that the consump-
tion of red meat, including beef, pork, lamb, and goat from domesticated animals, 
increases the risk for developing CRC [7, 8]. The evidence for red meat has consis-
tently shown a positive association in the dose-response meta-analyses for colorectal, 
colon, and rectal cancer. Despite the result being positive, it was not significant for 
colorectal and rectal cancers but significant for colon cancer. As there is evidence of 
plausible mechanisms operating in humans, the consumption of red meat is prob-
ably a cause of CRC [8]. In contrast to red meat, the consumption of poultry and fish 
has been associated with a modest reduction in CRC incidence. This is concordant 
with the concept that there are components other than fat and protein in red and 
processed meat that contribute to carcinogenic effects. Thus, based on current evi-
dence, it would be reasonable to recommend the substitution of red and processed 
meat with poultry or fish, as it can serve as a strategy for CRC prevention [4].
2.3.1 Mechanism
Red meat consists of compounds such as haem iron (HI) that facilitates the endog-
enous formation of N-nitroso compounds (NOCs) such as nitrosylated HI, catalyzing 
its formation from natural precursors in the gastrointestinal tract (GI), as well as 
through lipid peroxidation in the GI [4, 24, 25]. In addition, HI can induce oxidative 
stress, colonocyte proliferation through the lipid-peroxidation pathway, and produc-
tion of free radicals in the colonic stream [25]. The carcinogenic compounds forming 
during processing and cooking include NOCs and polycyclic aromatic hydrocarbons 
(PAHs) [25]. Cooking red or processed meat at high temperatures produces muta-
gens such as PAHs and heterocyclic aromatic amine (HAAs) [4, 25], both of which 
have been linked to CRC development in experimental studies [26]. The latter are 
genotoxic, and the extent to which HAAs’ conversion to genotoxic metabolites occurs 
as a result of amino acids and creatinine reacting at high cooking temperatures is 
higher in humans than experimental animals. HAAs become DNA-alkylating agents, 
inducing DNA mutations after activation by various metabolizing enzymes. The GI 
microbiota adapts to meat intake and HAAs, resulting in HAAs possibly becoming 
more genotoxic in those with a high meat intake. However, the majority of studies that 
have investigated meat and phenotype interactions did not yield convincing evidence. 
It is therefore probable though that heat-induced mutagens found on the surface of 
well-done red meat can cause colon cancer in those with a genetic predisposition. 
NOCs, PAHs, and HAAs are considered to be genotoxic by acting directly on DNA, 
causing point mutations, deletions, and insertions. However, there is little direct 
evidence that these mechanisms come into play following meat consumption. A high 
consumption of HI (excluding other forms of iron), NOCs, HAAs, and PAHs has been 
associated with an increased risk of colorectal tumors, with a few exceptions. Genetic 
variations in NOCs’ and HAAs’ metabolism may alter the relationship between the 
consumption of red meat and the risk of developing colon cancer. However, there is 
substantial supporting mechanistic evidence regarding HI, NOCs, and HAAs being 
involved in colon carcinogenesis. A high consumption of red meat (300–420 g/day), 
increased levels of DNA adducts, is presumed to be derived from NOCs, in exfoliated 
colonocytes or rectal biopsies [25].
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2.4 Processed meat
There is strong convincing evidence that consuming processed meat, i.e., meats 
preserved by smoking, curing, or salting, or addition of chemical preservatives, 
increases the risk of CRC [7, 8]. The evidence is generally consistent by showing an 
increased risk of CRC with increased consumption of processed meat. The dose-
response meta-analysis showed a significant increased risk of CRC at consumption 
levels of 50 g/day [8].
2.4.1 Mechanism
The carcinogenic compounds that form during processing include NOCs and 
PAHs. NOCs are exogenously introduced from nitrates and nitrites added during 
the preservation process [25, 27] but can also be formed endogenously. In processed 
meat, HI is nitrosylated because curing salt contains nitrate or nitrite. There is 
evidence that nitrosylated HI promotes carcinogenesis at doses that are five to six 
times lower than non-nitrosylated HI [25].
However, it is likely that a combination of mechanisms contribute to a higher 
risk of developing CRC among those who consume high quantities of processed 
meat. Similar to red meat, processed meat is high in fat, protein, and HI, which can 
promote carcinogenesis through the mechanisms described under red meat [25, 26]. 
In addition, processed meats such as sausages are often cooked at high tempera-
tures, leading to increased exposure to HAAs and PAHs [25, 27], with levels varying 
according to meat type, temperature, cooking time, and method [25]. The invari-
ably higher fat content of processed meat when compared to red meat may stimu-
late carcinogenesis through synthesis of secondary bile acids. However, human data 
supporting this hypothesis are weak [27].
2.5 Fruits
A dose-response meta-analysis showed no significant association between fruit 
consumption and CRC. There was evidence of a nonlinear dose response of CRC 
and fruit intake showing a significant increased risk at low levels (less than 100 g 
per day) of intake [7, 8]. Hence there is limited suggestive evidence available that a 
low consumption of fruit increases the risk of colorectal [8].
2.5.1 Mechanism
Apart from fiber content, fruits are a rich source of vitamins C and E, as well 
as numerous bioactive compounds which may have an anticarcinogenic potential. 
These include folate, flavonoids, polyphenols, and limonene [4, 28]. Many of these 
compounds have potent anti-oxidative properties which could inhibit cellular dam-
age and exposure to reactive oxygen species [28].
2.6 Non-starchy vegetables
Based on epidemiological studies, the term vegetables may cover different cat-
egories, namely, total vegetables (non-starchy vegetables and starchy vegetables), 
non-starchy vegetables, fresh vegetables (as opposed to preserved vegetables), 
and raw vegetables (excluding cooked vegetables) [7]. There is limited suggestive 
evidence that a low intake (less than 100 g per day) of cruciferous vegetables and 
non-starchy vegetables might increase the risk of CRC [7, 8]. However, there is 
also limited evidence that a high intake of fruits and vegetables protects against 
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CRC. Considering the well-establish cardiometabolic benefits of adequate fruit and 
vegetable intake, it would be reasonable to recommend increasing intake among 
populations with very low consumption [4].
2.6.1 Mechanism
The consumption of vegetables provides a large number of potential anticar-
cinogenic components that include dietary fiber, carotenoids, vitamins C and E, 
selenium, folate, dithiolethiones, glucosinolates and indoles, isothiocyanates, 
flavonoids, polyphenols, protease inhibitors, plant sterols, allium compounds, and 
limonene [7, 29]. It is possible that a combination of these nutrients and phytochemi-
cals is responsible for the lower CRC risks associated with vegetable consumption 
[8], due to their antioxidant and antiproliferative activities, modulating xenobiotic 
and hormonal metabolism and immunity [30, 31]. Vegetables are an important 
source of micronutrients, notably folate that plays an important role in DNA synthe-
sis and methylation and in the expression of genes involved in carcinogenesis [32]. 
Anticarcinogenic compounds such as folate, vitamins, fiber, minerals, flavonoids, 
and glucosinolates are found in cruciferous vegetables [4].
2.7 Alcoholic beverages
Alcoholic beverages contain ethanol that is formed during fermentation. In epi-
demiological studies, exposure to alcoholic beverages is examined by measures such 
as drinking or not, the number of drinks/glasses or 10 g units consumed per day or 
per week [7]. Concerning CRC associations, the evidence is considered to be convinc-
ing in men and probable in women [7, 33], as there is convincing evidence that the 
consumption of approximately two or more alcoholic drinks per day (30 g) increases 
the risk of CRC with a significant risk being observed for colorectal, colon, and rectal 
cancer [8]. An intake of 30 g per day is associated with a 16% increase in CRC risk, 
whereas an intake of 45 g per day increases the risk by 41% [34], suggesting a dose-
response relationship in which the higher the intake, the higher the risk [33].
2.7.1 Mechanism
The mechanisms whereby chronic alcohol consumption has an effect on the 
development of CRC are diverse. Acetaldehyde (the first compound formed in 
ethanol metabolism) has mutagenic and carcinogenic activity. It is thought that it 
plays a critical role in CRC onset via toxic metabolites of ethanol oxidation that can 
be carcinogenic to colonocytes [35, 36]. Higher ethanol consumption can also induce 
oxidative stress through the increased production of reactive oxygen species which are 
genotoxic and carcinogenic [37]. Alcohol may also act as a solvent for cellular penetra-
tion of dietary or environmental (e.g., tobacco) carcinogens, affect hormone metabo-
lism, and interfere with retinoid metabolism and with DNA repair mechanisms [38].
3. Vitamins
3.1 Vitamin C
There is limited suggestive evidence that consuming foods containing vitamin C might 
decrease the risk of colon cancer. However, no conclusion was drawn regarding rectal 
cancer [8]. Although the evidence was limited, it was generally consistent and the dose-
response meta-analysis showed a significant decreased risk at a level of 40 mg per day [8].
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3.1.1 Mechanism
The biological plausibility to support a protective effect of vitamin C on CRC 
development is related to its potency as an antioxidant, thereby reducing levels of 
reactive oxygen species, inhibiting lipid peroxidation, and reducing nitrates [4, 28]. 
Vitamin C has also been shown to inhibit carcinogen formation in experimental 
models and to protect DNA from mutagenic effects [39]. Other mechanisms include 
inhibition of cell proliferation, pro-apoptosis, and a reduction in inflammation [4].
3.2 Vitamin D
There is limited suggestive evidence that foods containing vitamin D, serum vita-
min D, and supplemental vitamin D might decrease the risk of CRC [8]. For foods 
containing vitamin D, a dose-response meta-analysis showed a significant decreased 
risk for CRC. For supplemental vitamin D, the dose-response meta-analysis showed 
a significant decreased risk for colon cancer, whereas for plasma/serum vitamin 
D, the dose-response meta-analysis did not exhibit a significant association with 
CRC. Two published meta-analyses reported significant inverse associations. Hence, 
the WCRF/AICR, Continuous Update Project report, noted that plasma/serum 
vitamin D status can be influenced by sun exposure, obesity, seasonality, smoking, 
and measurement error. There is evidence of plausible mechanisms in humans [8]. 
Convincing data from epidemiologic and experimental studies support the potential 
chemopreventive effects of vitamin D against CRC development, although the 
evidence from randomized controlled trials (RCTs) is inconclusive [4].
3.2.1 Mechanism
Underlying mechanisms for an effect of vitamin D on CRC have been predomi-
nantly studied in vitro and experimental models. Hence, limited data is available in 
humans [8]. However, these studies suggest a role of circulating vitamin D through 
its active form, 1 α, 12-dihydroxyvitamin D3 [1,12(OH)2D3], in controlling cell 
growth, by reducing proliferation and by inducing differentiation and apoptosis 
[4, 40]. Other alleged mechanisms related to a higher vitamin D status are related 
to improved innate and adaptive immune function, inhibition of angiogenesis, 
reduced inflammation, and regulation of microRNA expression [4, 40–42], as well 
as inhibition of invasion and metastasis and suppression of angiogenesis [4].
4. Body fatness
Body fatness and abdominal obesity is normally estimated by body mass index 
(BMI), waist circumference, and waist-to-hip ratio [7]. There is strong convincing 
evidence that body fatness increases the risk of colorectal, colon, and rectum cancer 
[7]. However, cognizance should be taken of the fact that these anthropometric 
measurements have limitations as they do not distinguish between lean and fat mass 
[8]. Evidence supporting a clear dose-response association was related to show-
ing a significant increased risk of CRC with an increased BMI [8, 43, 44]. There is 
evidence of a nonlinear dose response, whereby the increased risk is higher at a BMI 
beyond 27 kg/m2 for CRC. Significant positive associations were observed for CRC 
in the dose-response analysis for waist circumference and waist-to-hip ratio [8]; 
hence, the level of evidence is being referred to as convincing for abdominal obesity 
[33]. In contrast to the vague findings regarding the role of individual nutrients or 
foods, the strong consistent association between obesity and CRC (at least in men) 
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further underscores the importance of combined integrated effects of nutrients/
foods over their individual effects. These effects probably do not only reflect the 
imbalance between energy intake and expenditure but the often suboptimal quality 
of the diet associated with the development of obesity [4].
4.1 Mechanism
Overnutrition increases the supply of glucose and fat that can feed into meta-
bolic reprogramming to fuel cancer cell proliferation. In addition, glycolysis has 
been shown to be enhanced in cancer cells of obese individuals. As obesity is often 
associated with metabolic syndrome (MS) and diabetes, characterized by hypergly-
cemia and/or hypertriglyceridemia, an abundance of circulating nutrients are avail-
able for tumor development, even between feeding periods [45]. Autophagy, the 
process whereby cancer cells digest and recycle their cellular contents during peri-
ods of low nutrient availability, can provide cancer cells with lipids, amino acids, 
and nucleotides required for proliferation [46]. Obesity has been shown to induce 
autophagy, particularly in adipocytes [45]. These obesity-associated metabolic 
adaptations facilitate the development of cancer traits that include insensitivity to 
anti-growth signals, resistance to cell death, and deregulation of cellular energetics 
[47]. Hence, interactions between cancer cell energetics and systemic metabolism 
highlight unique therapeutic strategies and interventions, particularly among obese 
individuals, as cancer cells may be more sensitive to metabolic interference, having 
already committed to metabolic reprogramming [45].
In addition, obesity and MS are associated with abnormalities in insulin signal-
ing, growth factor signaling, and glucose metabolism [48]. One growth factor 
implicated in cancer risk and progression is insulin-like growth factor (IGF)-1. 
Hyperglycemia and hyperinsulinemia, diagnostic criteria of MS, increase IGF-1 
production and bioavailability. Furthermore, hyperglycemia suppresses IGF-1-
binding protein synthesis, while hyperinsulinemia promotes expression of growth 
hormone receptor and subsequent IGF-1 synthesis [48]. Growth and survival 
functions of IGF-1 give it the potential to have an impact on many characteristics of 
cancer, including sustained proliferative signaling, insensitivity to anti-growth sig-
nals, induction of angiogenesis, and metastatic potential [49]. As a result, elevated 
IGF-1 has been established as a risk factor for CRC [45].
Higher body fatness is associated with increased insulin levels, which can promote 
cell growth and inhibit apoptosis and has been linked to a greater risk of CRC in humans 
[50, 51] and in experimental studies [52]. Body fatness also stimulates the body’s 
inflammatory response, which can promote CRC development [53, 54]. Overall, there 
are convincing mechanistic data supporting a link between body fatness and CRC [8].
5. Physical activity
Physical activity (PA) includes all movements performed in daily life, includ-
ing sport, whether recreational or competitive [30], as well as that performed in 
occupational, transport, recreational, and household settings [7]. In epidemiologi-
cal studies, PA is computed by combining intensity, duration, and frequency of 
different types of PA, with subjects being classified into three levels of PA, namely, 
low, moderate, or high. PA is usually divided into four types of activity related to 
occupational, transport, recreational, and household settings. Total PA is calculated 
as the sum of the four types or any of the four types that are presented as all-type 
PA. Thus a major barrier to conducting meta-analyses is the disparity between the 
measures of PA [7].
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There is convincing evidence that all types of PA, when comparing the highest 
and lowest levels, are protective against colon cancer with a significant inverse asso-
ciation being observed for total PA and CRC. However, no significant associations 
were observed for rectal cancer and either total or recreational PA when compar-
ing the highest and lowest levels. For recreational PA and colon cancer risk, three 
published meta-analysis reported inverse associations. In addition, there is robust 
evidence for mechanisms operating in humans. However, dose-response relation-
ships could not be determined [7, 8]. The protective effect was similar for proximal 
and distal colon cancer and was stronger for men than women [7]. More physically 
active subjects had a 24% decreased risk of CRC compared to those who lead a 
more sedentary lifestyle [55]. It has been reported that those who exercise regularly 
decrease their CRC risk by 40%, regardless of BMI [56]. In addition, 30 min of daily 
moderate exercise result in an 11% reduction in CRC [57].
5.1 Mechanism
PA reduces body fatness and therefore has a beneficial effect on CRC risk, possibly 
due to a reduction in insulin resistance and inflammation [50, 53, 54]. However, it is 
unclear whether PA that is not accompanied by weight loss has a significant impact on 
these pathways. Other mechanisms through which PA may lower CRC risk include the 
stimulation of digestion and reduction of gastrointestinal (GI) transit time, although 
robust data to support this mechanism in humans is limited [58]. Overall, mechanistic 
data to support a link between PA and CRC are moderate in strength [8].
6. Supplementation
6.1 Calcium changes made to this section are indicated in blue
The Women’s Health Initiative failed to show a significant relationship between 
calcium supplementation and the risk of developing CRC among postmenopausal 
women [59], while a meta-analysis of cohort studies reported a significant inverse 
relationship for colon and CRC when comparing the highest to lowest levels of 
calcium supplementation [60]. As there is evidence of plausible mechanisms 
in humans, the Continuous Update Project (CUP) panel concluded that taking 
calcium supplements probably protect against CRC, based on evidence derived 
from a dosage of more than 200 mg per day [8]. The evidence was generally con-
sistent and showed inverse associations across a range of intakes (200–1000 mg). 
RCTs reported a nonsignificant inverse association for calcium and vitamin D 
supplementation compared to placebo, after excluding women using calcium or 
vitamin D supplements at baseline. Although no dose-response meta-analysis could 
be conducted, six of the eight cohort studies reported inverse associations [8]. 
Predominant evidence indicates an increased CRC risk among individuals with a 
calcium intake lower than 700–1000 mg/day. It would therefore be reasonable to 
encourage individuals to increase their calcium intake to a level above this range, 
while recognizing that available data yielded inconsistent results [4].
6.1.1 Mechanism
A proposed mechanism for the protective properties of calcium against CRC is 
its ability to bind to unconjugated bile acids and free fatty acids (FFAs), thereby 
limiting their toxic effects on the colorectum [4, 61]. Cell culture studies suggest 
that it may also suppress cell proliferation and promote cell differentiation and 
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apoptosis, likely by influencing different cell-signaling pathways [4, 62]. Calcium 
may also prevent colonic K-ras mutations and inhibit haem-induced promotion 
of colon carcinogenesis [63, 64]. In addition, calcium also inhibits oxidative DNA 
damage and modulates CRC-related cell-signaling pathways [4].
6.2  Multivitamins-multivitamins were kept under the heading of 
“Supplementation” as the content under “Vitamins” in Section 3 is related 
to vitamins derived from whole foods and not supplements
There is evidence that consuming multivitamin supplements might decrease the 
risk of CRC cancer [8]. However, the evidence is limited but generally consistent 
[8]. One RCT in men reported a nonsignificant inverse association for multivitamin 
supplementation compared to placebo. The analysis of highest versus lowest users 
of supplements showed a significant decreased risk of CRC. One published meta-
analysis on CRC and colon cancer reported significant inverse associations. There is 
evidence of plausible mechanisms in humans [8].
6.2.1 Mechanism
Multivitamin supplements consist of a combination of several, or in some 
instances, many vitamins, thereby making it challenging to determine what exactly 
the active ingredient is. Numerous vitamins included in multivitamin supplements 
have been shown to neutralize free radicals and reactive oxygen species and to 
prevent lipid peroxidation [65].
7. Conclusion
Based on the dietary- and lifestyle-related evidence presented, there is convinc-
ing evidence that PA decreases the risk of developing CRC, while the consumption 
of processed meat increases risk. In addition, the consumption of alcoholic bever-
ages is a convincing cause of CRC, as is higher body fatness. Probable evidence 
regarding a decreased risk for the development of CRC is available for the consump-
tion of wholegrains, foods containing dietary fiber, dairy products, and calcium 
supplements. There is also probable evidence that the consumption of red meat 
probably causes CRC. Limited suggestive evidence regarding the prevention of CRC 
exists for foods containing vitamin C and vitamin D and taking a multivitamin 
supplement, while the same level of evidence for increasing CRC risk is related to a 
low consumption of non-starchy vegetables and fruits.
For the prevention of cancer, it is recommended that the general population 
should strive toward maintaining a healthy weight, being physically active, eating a 
variety of foods, and limiting alcohol intake. However, recommendations aimed at 
the prevention of CRC, include keeping body weight within a healthy range, being 
physically active, making wholegrains, vegetables, fruit, and legumes a major part 
of the usual diet, and limiting the consumption of fast foods and other processed 
foods high in fat, starches, and sugars. Furthermore, red meat should be consumed 
in moderate amounts, while little if any processed meat should be consumed. It is 
best not to drink alcohol and not using supplements for the prevention of CRC.
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